StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) income statement

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$13.66−1.20 (-8.08%)

Close on Nov 20, 2026Market cap $2.76BP/E –Yield –

SELLAS Life Sciences Group, Inc. financial ratios

See a number that looks wrong?